← Evidence map

ReviewStem cell research & therapy2023

Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases.

Farnaz Sani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

6 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37226279